Metformin Prostate Cancer Adjuvant Trial
NCT02176161
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Prostate Cancer Recurrent
Interventions
DRUG:
Metformin Hydrochloride Extended Release 750mg
Sponsor
NYU Langone Health